CA
Calton & Associates Portfolio holdings
AUM
$578M
1-Year Return
14.11%
This Quarter Return
-2.45%
1 Year Return
+14.11%
3 Year Return
+51.24%
5 Year Return
+87.72%
10 Year Return
–
AUM
$337M
AUM Growth
-$38.2M
(-10%)
Cap. Flow
-$22.3M
Cap. Flow
% of AUM
-6.62%
Top 10 Holdings %
Top 10 Hldgs %
21.59%
Holding
421
New
56
Increased
123
Reduced
161
Closed
72
Top Buys
| 1 |
Vanguard Utilities ETF
VPU
|
$3.52M |
| 2 |
iShares Core High Dividend ETF
HDV
|
$2.46M |
| 3 |
Invesco S&P 500 Downside Hedged ETF
PHDG
|
$1.67M |
| 4 |
Pacer US Cash Cows 100 ETF
COWZ
|
$1.39M |
| 5 |
Invesco High Yield Equity Dividend Achievers ETF
PEY
|
$1.15M |
Top Sells
Sector Composition
| 1 | Technology | 10.34% |
| 2 | Financials | 3.26% |
| 3 | Consumer Discretionary | 3.09% |
| 4 | Healthcare | 2.85% |
| 5 | Industrials | 2.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Exelixis
EXEL
$10.2B
| $207K | 0.06% |
+9,137
| New | +$207K |
|
327
Invesco S&P 500 Low Volatility ETF
SPLV
$7.99B
| $207K | 0.06% |
3,096
-2,194
| -41% | -$147K |
|
328
Repligen
RGEN
$7.01B
| $204K | 0.06% |
1,089
-184
| -14% | -$34.5K |
|
329
Southern Company
SO
$101B
| $203K | 0.06% |
+2,811
| New | +$203K |
|
330
Vertex Pharmaceuticals
VRTX
$102B
| $202K | 0.06% |
774
-414
| -35% | -$108K |
|
331
Fulton Financial
FULT
$3.53B
| $194K | 0.06% |
11,676
-500
| -4% | -$8.31K |
|
332
TriplePoint Venture Growth BDC
TPVG
$275M
| $175K | 0.05% |
+10,031
| New | +$175K |
|
333
Allogene Therapeutics
ALLO
$246M
| $166K | 0.05% |
+18,329
| New | +$166K |
|
334
Amicus Therapeutics
FOLD
$2.46B
| $165K | 0.05% |
+17,520
| New | +$165K |
|
335
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.32B
| $160K | 0.05% |
12,209
-2,133
| -15% | -$28K |
|
336
Adaptive Biotechnologies
ADPT
$1.96B
| $157K | 0.05% |
+11,355
| New | +$157K |
|
337
SunCoke Energy
SXC
$667M
| $155K | 0.05% |
+17,481
| New | +$155K |
|
338
NeoGenomics
NEO
$1.03B
| $125K | 0.04% |
+10,355
| New | +$125K |
|
339
Monroe Capital Corp
MRCC
$164M
| $124K | 0.04% |
11,515
-245
| -2% | -$2.64K |
|
|
PMM
340
Putnam Managed Municipal Income
PMM
$257M
| $96K | 0.03% |
13,683
| – | – |
|
341
Omeros
OMER
$284M
| $95K | 0.03% |
15,889
+1,786
| +13% | +$10.7K |
|
342
Kamada
KMDA
$411M
| $94K | 0.03% |
17,158
-1,656
| -9% | -$9.07K |
|
343
CEL-SCI Corp
CVM
$72.2M
| $66K | 0.02% |
567
-136
| -19% | -$15.8K |
|
|
ADAM
344
Adamas Trust, Inc. Common Stock
ADAM
$669M
| $62K | 0.02% |
4,250
-246
| -5% | -$3.59K |
|
345
Nektar Therapeutics
NKTR
$764M
| $55K | 0.02% |
+690
| New | +$55K |
|
|
ATRS
346
DELISTED
Antares Pharma, Inc.
ATRS
| $51K | 0.02% |
12,500
+1,000
| +9% | +$4.08K |
|
347
Arcadia Biosciences
RKDA
$4.31M
| $18K | 0.01% |
325
| – | – |
|
|
PTN
348
DELISTED
Palatin Technologies
PTN
| $13K | ﹤0.01% |
1,200
+240
| +25% | +$2.6K |
|
349
TherapeuticsMD
TXMD
$12.5M
| $3K | ﹤0.01% |
+200
| New | +$3K |
|
|
ACB
350
Aurora Cannabis
ACB
$272M
| – | – |
-1,538
| Closed | -$83K |
|